ARTICLE | Clinical News
Rixubis regulatory update
September 22, 2014 7:00 AM UTC
FDA approved an sBLA from Baxter for Rixubis to control and prevent bleeding episodes, for perioperative management and for routine prophylactic use in children with hemophilia B. Last year, FDA appro...